THE EFFICACY AND COMPLICATIONS OF METFORMIN PRODUCED BY IRANIAN CO IN COMPARISON WITH CANADIAN CO

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

VALIZADEH MAJID; VALIZADEH SOHEILA; MAZLOUMZADEH S.; AMIR MOGHADAMI HAMID REZA; JAFARI MOHAMMAD REZA

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Journal of Advances in Medical and Biomedical Research Year:2011 | Volume:18 | Issue:73 Page(s): 1-10

Download Full-Text

Persian Verion

View:

34,273

Download:

Cites:

Information Journal Paper

Title

THE EFFICACY AND COMPLICATIONS OF METFORMIN PRODUCED BY IRANIAN CO IN COMPARISON WITH CANADIAN CO

Author(s)

Keywords

TYPE 2 DIABETESQ2

METFORMINQ2

EFFICACYQ3

COMPLICATIONSQ3

Abstract

Backgroundand Objective:Different pharmaceutical types of METFORMIN are available for glycemic control in TYPE 2 DIABETES mellitus. There is some doubt about the EFFICACY of METFORMIN produced by domestic pharmaceutical companies. As a clinical trial, we compared the EFFICACY and COMPLICATIONSof METFORMIN produced byan Iranian company with METFORMIN from a Canadian companyin diabetic patients.Materials and Methods:Eighteen eligible women (age range: 32-62 years) with TYPE 2 DIABETES received METFORMIN (500 mg twice a day) either from Iranian company or from Canadian company each for 6 weeks period in a randomized, double blind, crossover study. Fasting blood sugar (FBS), HbA1C, lipid profile (Chol, TG, HDL, and LDL), weight, and BMI were assessed before and after each treatment phase. The results were compared witheach other by paired sample T-test and Independent sample T-test.Results:Each of the two pharmaceutical types of METFORMIN had the same therapeutic effects on FBS, HbA1C, lipid profile (except for HDL) and BMI. In addition, there was no significant difference between them in side effects (22.2% in each group).Conclusion:According to the beneficial therapeutic effects of Iranian METFORMIN, lower side effects and low cost, in comparison to its Canadian type, it seems that using Iranian METFORMIN would be a suitable choice for control of glycemic patients. However, in this regard, further studies with greater samples are recommended.

Cites

No record.

References

No record.

Cite

APA: Copy

VALIZADEH, MAJID, VALIZADEH, SOHEILA, MAZLOUMZADEH, S., AMIR MOGHADAMI, HAMID REZA, & JAFARI, MOHAMMAD REZA. (2011). THE EFFICACY AND COMPLICATIONS OF METFORMIN PRODUCED BY IRANIAN CO IN COMPARISON WITH CANADIAN CO. JOURNAL OF ADVANCES IN MEDICAL AND BIOMEDICAL RESEARCH, 18(73), 1-10. SID. https://sid.ir/paper/61343/en

Vancouver: Copy

VALIZADEH MAJID, VALIZADEH SOHEILA, MAZLOUMZADEH S., AMIR MOGHADAMI HAMID REZA, JAFARI MOHAMMAD REZA. THE EFFICACY AND COMPLICATIONS OF METFORMIN PRODUCED BY IRANIAN CO IN COMPARISON WITH CANADIAN CO. JOURNAL OF ADVANCES IN MEDICAL AND BIOMEDICAL RESEARCH[Internet]. 2011;18(73):1-10. Available from: https://sid.ir/paper/61343/en

IEEE: Copy

MAJID VALIZADEH, SOHEILA VALIZADEH, S. MAZLOUMZADEH, HAMID REZA AMIR MOGHADAMI, and MOHAMMAD REZA JAFARI, “THE EFFICACY AND COMPLICATIONS OF METFORMIN PRODUCED BY IRANIAN CO IN COMPARISON WITH CANADIAN CO,” JOURNAL OF ADVANCES IN MEDICAL AND BIOMEDICAL RESEARCH, vol. 18, no. 73, pp. 1–10, 2011, [Online]. Available: https://sid.ir/paper/61343/en

Related Journal Papers